ARPINO, GRAZIA
 Distribuzione geografica
Continente #
AS - Asia 25
NA - Nord America 5
EU - Europa 2
SA - Sud America 1
Totale 33
Nazione #
SG - Singapore 20
MX - Messico 4
HK - Hong Kong 3
IT - Italia 2
BD - Bangladesh 1
BR - Brasile 1
IN - India 1
US - Stati Uniti d'America 1
Totale 33
Città #
Mexico City 4
Singapore 4
Hong Kong 3
Caxias do Sul 1
Conyers 1
Delhi 1
Dhaka 1
Totale 15
Nome #
Breast cancer prognosis in BRCA1/2 mutation carriers: A case control study 3
New steps on an old path: Novel estrogen receptor inhibitors in breast cancer 3
Tumor characteristics and prognosis in familial breast cancer 3
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type 3
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054] 3
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer 3
Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications 3
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series 2
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 2
Prevalence of Sarcopenia in Women with Breast Cancer 2
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study 2
Triple-negative breast cancers: Biomarkers and outcomes 2
New steps on an old path: Novel estrogen receptor inhibitors in breast cancer 2
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review 2
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests 2
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study 2
Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis 2
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up 2
Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients 2
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study 2
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 2
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 2
Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer 2
Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis 2
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations 2
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer 2
The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment 1
Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study 1
GMO-Gestione Malattie Oncologiche in Regione Campania 1
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study 1
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era 1
Overcoming treatment resistance in HER2-positive breast cancer: potential strategies 1
Ribociclib in newly diagnosed hepatitis B infection: A case report 1
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a 1
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study 1
A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer 1
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 1
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 1
Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis 1
Totale 72
Categoria #
all - tutte 418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202542 0 0 0 0 0 0 0 0 0 0 0 42
2025/202630 16 8 6 0 0 0 0 0 0 0 0 0
Totale 72